Ganglioneuroma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ganglioneuroma}} | {{Ganglioneuroma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{SR}} | ||
==Overview== | ==Overview== | ||
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on [[clinical]], radiologic, and [[surgical]] features.<ref name="pmid19047290">{{cite journal| author=Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K et al.| title=The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. | journal=J Clin Oncol | year= 2009 | volume= 27 | issue= 2 | pages= 298-303 | pmid=19047290 | doi=10.1200/JCO.2008.16.6876 | pmc=PMC2650389 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19047290 }} </ref> | |||
==Staging== | |||
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on [[clinical]], radiologic, and [[surgical]] features.<ref name="pmid19047290">{{cite journal| author=Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K et al.| title=The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. | journal=J Clin Oncol | year= 2009 | volume= 27 | issue= 2 | pages= 298-303 | pmid=19047290 | doi=10.1200/JCO.2008.16.6876 | pmc=PMC2650389 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19047290 }} </ref> | |||
'''Stage 1''' | |||
*Localized tumor confined to the area of origin | |||
*Complete gross excision, with or without microscopically residual disease | |||
*Identifiable ipsilateral and contralateral lymph node negative microscopically | |||
'''Stage 2A''' | |||
*Unilateral tumor with incomplete gross excision | |||
*Identifiable ipsilateral nonadherent lymph node negative microscopically | |||
'''Stage 2B''' | |||
*Unilateral tumor with complete or incomplete gross excision | |||
*Positive ipsilateral nonadherent lymph nodes | |||
*Identifiable contralateral lymph node negtive microscopically | |||
'''Stage 3''' | |||
*Tumor infiltrating across the midline (vertebral column) with or without regional lymph node involvement | |||
:or | |||
*Unilateral tumor with contraateral regional lymph node involvement | |||
:or | |||
*Midline tumor with bilateral regional lymph node involvement or extension by infiltration | |||
==References== | ==References== | ||
Revision as of 13:31, 10 September 2015
|
Ganglioneuroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ganglioneuroma staging On the Web |
|
American Roentgen Ray Society Images of Ganglioneuroma staging |
|
Risk calculators and risk factors for Ganglioneuroma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]
Staging
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]
Stage 1
- Localized tumor confined to the area of origin
- Complete gross excision, with or without microscopically residual disease
- Identifiable ipsilateral and contralateral lymph node negative microscopically
Stage 2A
- Unilateral tumor with incomplete gross excision
- Identifiable ipsilateral nonadherent lymph node negative microscopically
Stage 2B
- Unilateral tumor with complete or incomplete gross excision
- Positive ipsilateral nonadherent lymph nodes
- Identifiable contralateral lymph node negtive microscopically
Stage 3
- Tumor infiltrating across the midline (vertebral column) with or without regional lymph node involvement
- or
- Unilateral tumor with contraateral regional lymph node involvement
- or
- Midline tumor with bilateral regional lymph node involvement or extension by infiltration
References
- ↑ 1.0 1.1 Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K; et al. (2009). "The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report". J Clin Oncol. 27 (2): 298–303. doi:10.1200/JCO.2008.16.6876. PMC 2650389. PMID 19047290.